Skip to content
★ Sign in to follow
RJ

Robert J. Israel

Progenics Pharmaceuticals Inc
Total declarations
175
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (62 ops.)
€2.2M

Latest filing published 15 Jun 2015 for PROGENICS PHARMACEUTICALS INC, €9,483.

Insider track record

Disclosed buys
0
Disclosed sells
62
Signal history

No signal scores available.

Robert J. Israel: trading record in brief

Robert J. Israel is a declared insider of Progenics Pharmaceuticals Inc, with filings sourced from SEC (Form 4). Over a trading history stretching from 3 January 2006 to 11 June 2015, the count stands at 175 filings.

Sales make up the whole of the open-market record (62 sales, €2.2M). The rest of the record consists of 28 share grants and 82 option exercises. So far in 2015, the count stands at no purchases and 5 sales.

The newest entry dates from 15 June 2015: an option exercise of €9,483, in Progenics Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Robert J. Israel

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations174 total

25 of 174 declarations